Yamamoto N - Search Results

1

A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production.

Hamano T, Matsuo K, Hibi Y, Victoriano AF, Takahashi N, Mabuchi Y, Soji T, Irie S, Sawanpanyalert P, Yanai H, Hara T, Yamazaki S, Yamamoto N, Okamoto T. Hamano T, et al. Among authors: yamamoto n. J Virol. 2007 Feb;81(3):1528-33. doi: 10.1128/JVI.01596-06. Epub 2006 Nov 22. J Virol. 2007. PMID: 17121798 Free PMC article.

2

Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.

Okuma K, Matsuura Y, Tatsuo H, Inagaki Y, Nakamura M, Yamamoto N, Yanagi Y. Okuma K, et al. Among authors: yamamoto n. J Gen Virol. 2001 Apr;82(Pt 4):821-830. doi: 10.1099/0022-1317-82-4-821. J Gen Virol. 2001. PMID: 11257187

3

Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen.

Kawahara M, Matsuo K, Nakasone T, Hiroi T, Kiyono H, Matsumoto S, Yamada T, Yamamoto N, Honda M. Kawahara M, et al. Among authors: yamamoto n. Vaccine. 2002 Dec 13;21(3-4):158-66. doi: 10.1016/s0264-410x(02)00465-6. Vaccine. 2002. PMID: 12450689

4

Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.

Izumi Y, Ami Y, Matsuo K, Someya K, Sata T, Yamamoto N, Honda M. Izumi Y, et al. Among authors: yamamoto n. J Virol. 2003 Dec;77(24):13248-56. doi: 10.1128/jvi.77.24.13248-13256.2003. J Virol. 2003. Retraction in: J Virol. 2005 Mar;79(5):3229. doi: 10.1128/JVI.79.5.3229.2005 PMID: 14645581 Free PMC article. Retracted.

5

Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.

Kanamori M, Watanabe S, Honma R, Kuroda M, Imai S, Takada K, Yamamoto N, Nishiyama Y, Kawaguchi Y. Kanamori M, et al. Among authors: yamamoto n. J Virol. 2004 Apr;78(8):3984-93. doi: 10.1128/jvi.78.8.3984-3993.2004. J Virol. 2004. PMID: 15047814 Free PMC article.

6

Determination of HIV type 1 CRF01_AE gag p17 and env-V3 consensus sequences for HIV/AIDS vaccine design.

Hamano T, Sawanpanyalert P, Yanai H, Piyaworawong S, Hara T, Sapsutthipas S, Phromjai J, Yamazaki S, Yamamoto N, Warachit P, Honda M, Matsuo K. Hamano T, et al. Among authors: yamamoto n. AIDS Res Hum Retroviruses. 2004 Mar;20(3):337-40. doi: 10.1089/088922204322996572. AIDS Res Hum Retroviruses. 2004. PMID: 15117457

7

A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.

Someya K, Xin KQ, Matsuo K, Okuda K, Yamamoto N, Honda M. Someya K, et al. Among authors: yamamoto n. J Virol. 2004 Sep;78(18):9842-53. doi: 10.1128/JVI.78.18.9842-9853.2004. J Virol. 2004. PMID: 15331719 Free PMC article.

8

Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.

Someya K, Cecilia D, Ami Y, Nakasone T, Matsuo K, Burda S, Yamamoto H, Yoshino N, Kaizu M, Ando S, Okuda K, Zolla-Pazner S, Yamazaki S, Yamamoto N, Honda M. Someya K, et al. Among authors: yamamoto h, yamamoto n. J Virol. 2005 Feb;79(3):1452-62. doi: 10.1128/JVI.79.3.1452-1462.2005. J Virol. 2005. PMID: 15650171 Free PMC article.

9

Intravenous inoculation of replication-deficient recombinant vaccinia virus DIs expressing simian immunodeficiency virus gag controls highly pathogenic simian-human immunodeficiency virus in monkeys.

Izumi Y, Ami Y, Matsuo K, Someya K, Sata T, Yamamoto N, Honda M. Izumi Y, et al. Among authors: yamamoto n. J Virol. 2005 Mar;79(5):3229. doi: 10.1128/JVI.79.5.3229.2005. J Virol. 2005. PMID: 15709047 Free PMC article. No abstract available.

10

Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.

Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z. Miyauchi K, et al. Among authors: yamamoto n. J Virol. 2005 Apr;79(8):4720-9. doi: 10.1128/JVI.79.8.4720-4729.2005. J Virol. 2005. PMID: 15795258 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,401 results

Search Page

Filters